ReviewFrontiers in immunology2022

Adenosinergic axis and immune checkpoint combination therapy in tumor: A new perspective for immunotherapy strategy.

Zhaoyun Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.